Does Rallies show Form 4 insider transactions for TWST?

Yes. Rallies tracks TWST insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TWST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TWST. It does not provide personalized investment advice.

TWST (Twist Bioscience Corporation Common Stock) Stock Analysis - Insider Trades

Twist Bioscience Corporation Common Stock (TWST) is a publicly traded Healthcare sector company. As of May 21, 2026, TWST trades at $54.23 with a market cap of $3.10B and a P/E ratio of -40.03. TWST moved +8.46% today. Year to date, TWST is +56.26%; over the trailing twelve months it is +73.60%. Its 52-week range spans $23.30 to $66.06. Analyst consensus is strong buy with an average price target of $63.43. Rallies surfaces TWST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TWST stock inside the company?

Recent TWST insider activity includes JOHANNESSEN JAN sold 12.00K, WERNER ROBERT F. sold 4.96K, Cho Dennis sold 1.96K, Leproust Emily M. sold 5.13K, and Finn Patrick John sold 2.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TWST Key Metrics

Key financial metrics for TWST
Metric	Value
Price	$54.23
Market Cap	$3.10B
P/E Ratio	-40.03
EPS	$-1.32
Dividend Yield	0.00%
52-Week High	$66.06
52-Week Low	$23.30
Volume	512
Avg Volume	0
Revenue (TTM)	$409.48M
Net Income	$-81.28M
Gross Margin	52.07%

Recent TWST Insider Trades

JOHANNESSEN JAN sold 12.00K (~$673.44K) on May 12, 2026.
WERNER ROBERT F. sold 4.96K (~$282.19K) on May 8, 2026.
Cho Dennis sold 1.96K (~$112.13K) on May 4, 2026.
Leproust Emily M. sold 5.13K (~$293.00K) on May 4, 2026.
Finn Patrick John sold 2.84K (~$162.53K) on May 4, 2026.

Latest TWST News

Twist Bioscience Posts 13th Straight Growth, Sees 28% DNA and 55% Therapeutics Gains — May 4, 2026
Twist Bioscience Posts 17% Q1 Revenue Growth, Raises 2026 Outlook to $435–$440M — Feb 3, 2026
Twist Bioscience Raises 2026 Guide to $435–440M as Q1 Revenue Jumps 17% — Feb 2, 2026
Twist Bioscience’s Q1 Loss of $0.50 per Share Misses Zacks Estimate — Feb 2, 2026
Twist Bioscience Schedules Preliminary Q1 Fiscal 2026 Revenue Release on Feb. 2 — Jan 13, 2026

TWST Analyst Consensus

7 analysts cover TWST: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $63.43.

Common questions about TWST

Who is trading TWST stock inside the company?: Recent TWST insider activity includes JOHANNESSEN JAN sold 12.00K, WERNER ROBERT F. sold 4.96K, Cho Dennis sold 1.96K, Leproust Emily M. sold 5.13K, and Finn Patrick John sold 2.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TWST?: Yes. Rallies tracks TWST insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TWST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TWST. It does not provide personalized investment advice.